Current perspectives on Kawasaki disease

Indian Journal of Pediatrics

Volumn 72, Issue 7, 2005, Pages 621-629

  Gupta Malhotra, Monesha ^a,b   Rao, P Syamasundar ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MSB 3130 ^*  (United States)

Author keywords

Coronary artery aneurysms; Intravenous gamma globulin; Kawasaki disease

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; IBUPROFEN; IMMUNOGLOBULIN; INFLIXIMAB; PENTOXIFYLLINE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CORONARY ARTERY ANEURYSM; CORONARY ARTERY ANOMALY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONAVIRUS; DRUG ANTAGONISM; DRUG MECHANISM; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENETIC POLYMORPHISM; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LABORATORY TEST; MUCOCUTANEOUS LYMPH NODE SYNDROME; NERVE PARALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; VIRUS INFECTION;

EID: 23844507132     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02724189     Document Type: Conference Paper

References (86)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967; 16: 178.
2. Mirza I, Gribbin B, Forfar C. A young man with myocardial infarction and a calcified coronary artery aneurysm on chest radiography. Int J Clin Pract 2004; 58(11): 1050-1051.
3. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 1996; 28: 253-257
4. Rowley AH, Shulman ST, Mask CA, Finn LS, Terai M, Baker SC, Galliani CA, Takahashi K, Naoe S, Kalelkar MB et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis 2000; 182: 1183-1191.
5. Rowley AH, Eckerley CA, Jack HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997 Dec 15; 159(12): 5946-5955.
6. Wong D, Nutting A, Yeung RS, McCrindle BW. Kawasaki disease and scald injuries: a possible association. Can J Cardiol 2004; 20(11): 1147-1149.
7. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis 2005 15; 191(4): 499-502.
8. Martinez-Escribano JA, Redondo C, Galera C, Sanchez-Pedreno P, Abel JL, Frias JF. Recurrent Kawasaki syndrome in an adult with HIV-1 infection. Dermatology 1998; 197: 96-97.
9. Lee DH, Huang HP. Kawasaki disease associated with chickenpox: report of two sibling cases. Acta Paediatr Taiwan 2004; 45(2): 94-96.
10. Hall M, Hoyt L, Ferrieri P, Schlievert PM, Jenson HB. Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus. Clin Infect Dis 1999; 29(3): 586-589
11. Nomura Y, Masuda K, Yoshinaga M, Takei S, Miyata K. Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age. Pediatr Infect Dis J 2003; 22(9): 794-798.
12. Yoshioka T, Matsutani T, Toyosaki-Maeda T, Suzuki H, Uemura S, Suzuki R, Koike M, Hinuma Y. Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease. Pediatr Res 2003; 53(3): 403-410.
13. Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993; 342(8884): 1385-1388.
14. Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, Myones BL, Wheeler JG, Ruthazer R, Schlievert PM. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr 2002; 140(6): 742-746.
15. Gupta-Malhotra M, Viteri-Jackson A, Thomas W, Zabriskie JB. Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease. Exp Mol Pathol 2004; 76(2): 117-121.
16. Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr 2001; 90: 40-44.
17. Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, Mizuno Y, Hara T. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 2004; 56(6): 953-959.
18. Onouchi Y, Onoue S, Tamari M, Wakui K, Fukushima Y, Yashiro M, Nakamura Y, Yanagawa H, Kishi F, Ouchi K, Terai M, Hamamoto K, Kudo F, Aotsuka H, Sato Y, Nariai A, Kaburagi Y, Miura M, Saji T, Kawasaki T, Nakamura Y, Hata A CD40 ligand gene and Kawasaki disease. Eur J Hum Genet 2004; 12(12): 1062-1068.
19. Wu SF, Chang JS, Peng CT, Shi YR, Tsai FJ. Polymorphism of angiotensin-1 converting enzyme gene and Kawasaki disease. Pediatr Cardiol 2004; 25(5): 529-533.
20. Naoe S, Shibuya K, Takahashi K, Wakayama M, Masuda H, Tanaka M. Pathologic observations concerning the cardiovascular lesions in Kawasaki disease. Cardiol Young 1991; 1: 212-220
21. Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann-Liang R. Cytokine modulation with immune gammaglobulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. J Clin Immunol 2001; 21: 193-199.
22. Leung DYM, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989; 2: 1298-1301
23. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-12
24. Nash MC, Shah V, Dillon MJ. Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin Exp Immunol 1995; 101: 13-17.
25. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 2001; 104(8): 860-863.
26. Matsubara T, Umezawa Y, Tsuru S, Motohashi T, Yabuta K, Furukawa S. Decrease in the concentrations of transforming growth factor - beta 1 in the sera of patients with Kawasaki disease. Scandinavian Journal of Rheumatology 1997; 26: 314-317.
27. Shi G-P, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Investigation 1999; 104: 1191-1197.
28. Gupta-Malhotra M, Levine DM, Cooper RS, Zabriskie JB. Decreased levels of cystatin C, an inhibitor of the elastolytic enzyme cysteine protease, in acute and subacute phases of kawasaki disease. Cardiology 2003; 99(3): 121-125.
29. Furukawa S, Matsubara T, Jujo K, Sasai K, Sugawara T et al. Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gamma globulin. Eur J Pediatr 1990; 150: 43-47.
30. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, Takahashi M, Bierman FZ, Karchmer AW, Wilson W, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87: 1776-1780.
31. Kuniyuki S, Asada M. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease. J Am Acad Dermatol 1997; 37: 303-304.
32. Tashiro N, Matsubara T, Uchida M, Katayama K, Ichiyama T, Furukawa S. Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease. Pediatrics 2002; 109: E77
33. Zulian F, Falcini F, Zancan L, Martini G, Secchieri S, Luzzatto C, Zacchello F. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr 2003; 142: 731-735.
34. Sundel RP, Newburger JW, McGill T, Cleveland SS, Miller WW, Berry B, Klein AM, Burns JC. Sensorineural hearing loss associated with Kawasaki disease. J Pediatr 1990; 117: 371-377.
35. Amano S, Hazama F. Neutral involvement in kawasaki disease. Acta Pathol Jpn 1980; 30(3): 365-373.
36. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004; 114(6): 1708-1733.
37. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Ministry of Health and Welfare; 1984.
38. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998; 133: 254-258.
39. Ravekes WJ, Colan SD, Gauvreau K, Baker AL, Sundel RP, van der Velde ME, Fulton DR, Newburger JW. Aortic root dilation in Kawasaki disease. Am J Cardiol 2001; 87: 919-922.
40. Kuramochi Y, Ohkubo T, Takechi N, Ogawa S. Feasibility of percutaneous transluminal coronary angioplasty to patients with Kawasaki Disease as an early management strategy. Pediatr Cardiol 2001; 22(3): 183-187.
41. Duerinckx A, Troutman B, Allada V, Kim D. Coronary MR angiography in Kawasaki disease. Am J Roentgenol 1997; 168: 114-116.
42. Greil GF, Stuber M, Botnar RM, Kissinger KV, Geva T, Newburger JW, Manning WJ, Powell AJ. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation 2002; 105: 908-911.
43. Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Baras P, Nikolaidou P, Bakoula C, Karanasios E, Manginas A, Cokkinos DV. Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol 2004; 43(4): 649-652.
44. Frey EE, Matherne GP, Mahoney LT, Sato Y, Stanford W, Smith WL. Coronary artery aneurysms due to Kawasaki disease: diagnosis with ultrafast CT. Radiology 1988; 167: 725-726.
45. Sato Y, Kato M, Inoue F, Fukui T, Imazeki T, Mitsui M, Matsumoto N, Takahashi M, Karasawa K, Ayusawa M. Detection of coronary artery aneurysms, stenoses and occlusions by multislice spiral computed tomography in adolescents with kawasaki disease. Circ J 2003; 67: 427-430.
46. Nakamura Y, Yashiro M, Oki I, Tanihara S, Ojima T, Yanagawa H. Giant coronary aneurysms due to Kawasaki disease: A case-control study. Pediatr Int 2002; 44: 254-258.
47. Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 2003; 24(2): 122-126.
48. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991; 33(6): 805-810.
49. Nofech-Mozes Y, Garty BZ. Thrombocytopenia in Kawasaki disease: a risk factor for the development of coronary artery aneurysms. Pediatr Hematol Oncol 2003; 20(8): 597-601.
50. Nakano H, Ueda K, Saito A, Tsuchitani Y, Kawamori J, Miyake T, Yoshida T. Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms. Am J Cardiol 1986; 58(9): 739-742.
51. Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Sonobe T, Yanagawa H. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 2004; 46(1): 33-38.
52. Takahashi M, Mason W, Thomas D, Sinatra F. Reye syndrome following Kawasaki syndrome confirmed by liver histopathology. In: Kato H, ed. Kawasaki Disease. Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, 22-25 May 1995. New York, NY: Elsevier Science; 1995:436-444.
53. Lee JH, Hung HY, Huang FY. Kawasaki disease with Reye syndrome: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1992; 33: 67-71
54. Nejihashi Y, Takada Y, Okazaki T et al. An autopsied case of Reye syndrome in progress of MCLS. Shonika Shinryo (J Pediatr Practice) 1980; 43: 960-962.
55. Muta H, Ishii M, Egami K, Furui J, Sugahara Y, Akagi T, Nakamura Y, Yanagawa H, Matsuishi T. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr 2004; 144: 496-499.
56. Fong NC, Hui YW, Li CK, Chiu MC. Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness. Pediatr Cardiol 2004; 25: 31-34.
57. Fukunishi M, Kikkawa M, Hamana K, Onodera T, Matsuzaki K, Matsumoto Y, Hara J. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000; 137(2): 172-176.
58. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics. 2000; 105: E78.
59. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996; 128: 146-149
60. Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS. Infliximab as a novel therapy for refractory Kawasaki disease. J Rheumatol 2004; 31(4): 808-810.
61. Takagi N, Kihara M, Yamaguchi S, Tamura K, Yabana M, Tokita Y, Ishii M. Plasma exchange in Kawasaki disease. Lancet. 1995; 346: 1307.
62. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000; 105(6): E78
63. Raman V, Kim J, Sharkey A, Chatila T. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy. Pediatr Infect Dis J 2001; 20(6): 635-637.
64. Zaitsu M, Hamasaki Y, Tashiro K, Matsuo M, Ichimaru T, Fujita I, Tasaki H, Miyazaki S. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis 2000; 181(3): 1101-1109.
65. Kato H, Inoue O, Ichinose E, Akagi T, Sato N. Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction. Acta Paediatr Jpn 1991; 33(1): 27-35.
66. Nakagawa M, Watanabe N, Okuno M, Okamoto N, Fujino H. Effects of intracoronary tissue-type plasminogen activator treatment in kawasaki disease and acute myocardial infarction. Cardiology 2000; 94(1): 52-57.
67. Tsubata S, Ichida F, Hamamichi Y, Miyazaki A, Hashimoto I, Okada T. Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease. Pediatr Cardiol 1995; 16(4): 186-189.
68. Williams RV, Wilke VM, Tani LY, Minich LL. Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics 2002; 109(1): E4.
69. Orrego PS, Pezzano A, Muriesan H, Belli G, Klugmann S. A rare case: surviving acute left main coronary artery occlusion in Kawasaki's disease. G Ital Cardiol 1999; 29(11): 1323-1326.
70. Ishii M, Ueno T, Akagi T, Baba K, Harada K, Hamaoka K, Kato H, Tsuda E, Uemura S, Saji T et al. Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int 2001; 43: 558-562.
71. Ino T, Akimoto K, Ohkubo M, Nishimoto K, Yabuta K, Takaya J, Yamaguchi H. Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. Circulation 1996; 93: 1709-1715.
72. Sugimura T, Yokoi H, Sato N, Akagi T, Kimura T, Iemura M, Nobuyoshi M, Kato M. Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease. Circulation 1997; 96: 3928-3933.
73. Ishii M, Ueno T, Akagi T, Baba K, Harada K, Hamaoka K, Kato H, Tsuda E, Uemura S, Saji T et al. Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int 2001; 43: 558-562.
74. Ishii M, Ueno T, Ikeda H, Iemura M, Sugimura T, Furui J, Sugahara Y, Muta H, Agaki T, Nomura Y et al. Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 2002; 105: 3004-3010.
75. Checchia PA, Pahl E, Shaddy RE, Shulman ST. Cardiac transplantation for Kawasaki disease. Pediatrics 1997; 100: 695-699
76. Liu A, Ghazizadeh M, Onouchi Z, Asano G. Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease. Microvascular Res 1999; 58: 10-27
77. Mitani Y, Okuda Y, Shimpo H, Uchida F, Hamanaka K, Aoki K, Sakurai M. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation 1997; 95: 454-461.
78. Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, Dillon MJ, Deanfield JE. Endothelial dysfunction late after Kawasaki disease. Circulation 1996; 94: 2103-106.
79. Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid profile after Kawasaki syndrome. Circulation 1991; 84: 625-631.
80. Salo E, Pesonen E, Viikari J. Serum cholesterol levels during and after Kawasaki disease. J Pediatr 1991; 119: 557-561.
81. Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol 2004; 43: 120-124.
82. Sakata K, Onouchi Z. Plasma thrombomodulin levels in patients with Kawasaki disease in long-term periods. Jpn Pediatr. Soc 1993; 97: 93-96
83. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Col Cardiol 1996; 28: 253-257
84. Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, Sumitomo N, Harada K. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 2001; 107(5): 1095-1099.
85. Cheung YF, Ho MH, Tam SC, Yung TC. Increased high sensitivity Creactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 2004; 90(11): 1281-1285.
86. Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki syndrome: a pathologic study. J Pediatr 1982; 100: 225-231.